- About
- Specialties & Areas of Expertise
- Locations & Patient Information
- Education & Research
- Accepted Insurance
Rita Nanda, MD, specializes in the treatment of all forms of breast cancer. Dr. Nanda’s practice focuses on women with triple-negative, hereditary, locally advanced and metastatic breast cancers. She is a strong advocate of using chemotherapy prior to surgery (neoadjuvant chemotherapy) to better understand how an individual's tumor responds to therapy, so that treatment can be tailored to each patient's unique case.
Dr. Nanda’s research interests include identifying new and better treatments for the management of breast cancer. She leads the UChicago Medicines breast cancer clinical trial program. She has extensive knowledge of clinical trials and new therapies in development for all forms of advanced breast cancer. She serves as a principal investigator for the Translational Breast Cancer Research Consortium (TBCRC) and the I-SPY 2 Clinical Trial Network.
Dr. Nanda’s research has been funded by the National Institutes of Health (NIH), the Department of Defense Breast Cancer Research Program, the Doris Duke Charitable Foundation, the Susan G. Komen Foundation, and the Metastatic Breast Cancer Network. She currently serves as a co-principal investigator on the University of Chicago’s Interdisciplinary Cancer Health Disparities P20 SPORE.
Dr. Nanda’s research interests include identifying new and better treatments for the management of breast cancer. She leads the UChicago Medicines breast cancer clinical trial program. She has extensive knowledge of clinical trials and new therapies in development for all forms of advanced breast cancer. She serves as a principal investigator for the Translational Breast Cancer Research Consortium (TBCRC) and the I-SPY 2 Clinical Trial Network.
Dr. Nanda’s research has been funded by the National Institutes of Health (NIH), the Department of Defense Breast Cancer Research Program, the Doris Duke Charitable Foundation, the Susan G. Komen Foundation, and the Metastatic Breast Cancer Network. She currently serves as a co-principal investigator on the University of Chicago’s Interdisciplinary Cancer Health Disparities P20 SPORE.
Specialties
Areas of Expertise
UChicago Medicine Duchossois Center for Advanced Medicine - Hyde Park5758 S. Maryland Ave., Chicago IL 606371-888-824-0200
Board Certifications
- Medical Oncology
Practicing Since
- 2005
Languages Spoken
- English
Medical Education
- University of Chicago Pritzker School of Medicine
Residency
- University of Chicago Medicine
Fellowship
- University of Chicago Medicine
Memberships & Medical Societies
- American Association for Cancer Research
- Society for Immunotherapy of Cancer
- American Society of Clinical Oncology
News & Research
Insurance
- Aetna Better Health *see insurance page
- Aetna HMO (specialists only)
- Aetna Medicare Advantage HMO & PPO
- Aetna POS
- Aetna PPO
- BCBS Blue Precision HMO (specialists only)
- BCBS HMO (HMOI) (specialists only)
- BCBS Medicare Advantage HMO & PPO
- BCBS PPO
- Cigna HMO
- Cigna POS
- Cigna PPO
- CountyCare *see insurance page
- Humana Medicare Advantage Choice PPO
- Humana Medicare Advantage Gold Choice PFFS
- Humana Medicare Advantage Gold Plus HMO
- Medicare
- Multiplan PPO
- PHCS PPO
- United Choice Plus POS/PPO
- United Choice HMO (specialists only)
- United Options (PPO)
- United Select (HMO & EPO) (specialists only)
- United W500 Emergent Wrap
- University of Chicago Health Plan (UCHP)
Our list of accepted insurance providers is subject to change at any time. You should contact your insurance company to confirm UChicago Medicine participates in their network before scheduling your appointment. If your insurance company is not listed here, or if you have any other questions, please contact Managed.Care@uchospitals.edu.